CROCuS, a Phase II Study Evaluating the Antiviral Activity, Clinical Outcomes, and Safety of Rilematovir in Children Aged ≥ 28 Days and ≤ 3 Years with Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus

1. Ferrero, F.
2. Lin, C.-Y.
3. Liese, J.
4. Luz, K.
5. Stoeva, T.
6. Nemeth, A.
7. Gijón, M.
8. Calvo, C.
9. Natalini, S.
10. Toh, T.-H.
11. Deleu, S.
12. Chen, B.
13. Rusch, S.
14. Sánchez, B.L.
15. Leipoldt, I.
16. Vijgen, L.
17. Huntjens, D.
18. Baguet, T.
19. Bertzos, K.
20. Gamil, M.
21. Stevens, M.